Rakkoo Chung

Rakkoo Chung

Auto-generated profile, based on publicly available information

Rakkoo Chung

Center for Program Development, Implementation, Research and Evaluation

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Annals of Epidemiology
Verified
Journal Article
Closed access
EREli S. Rosenberg
Eli S. Rosenberg
JTJames M. Tesoriero
James M. Tesoriero
ERElizabeth M. Rosenthal
Elizabeth M. Rosenthal
RCRakkoo Chung
Rakkoo Chung
MBMeredith A. Barranco
Meredith A. Barranco
HZHoward A. Zucker
Howard A. Zucker

29 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
EREli S. Rosenberg
Eli S. Rosenberg
JTJames M. Tesoriero
James M. Tesoriero
ERElizabeth M. Rosenthal
Elizabeth M. Rosenthal
RCRakkoo Chung
Rakkoo Chung
MBMeredith A. Barranco
Meredith A. Barranco
HZHoward A. Zucker
Howard A. Zucker
Importance: New York State (NYS) is an epicenter of the United States’ COVID-19 epidemic. Reliable estimates of cumulative incidence of SARS-CoV-2 infection in the population are critical to tracking the extent of transmission and informing policies, but US data are lacking, in part because societal closure complicates study conduct. Objective: To estimate the cumulative incidence of SARS-CoV-2 infection and percent of infections diagnosed in New York State, overall and by region, age, sex, and race and ethnicity. Design: Statewide cross-sectional seroprevalence study, conducted April 19-28, 2020. Setting: Grocery stores (n=99) located in 26 counties throughout NYS, which were essential businesses that remained open during a period of societal closure and attract a heterogenous clientele. Participants: Convenience sample of patrons ≥18 years and residing in New York State, recruited consecutively upon entering stores and via an in-store flyer. Exposures: Region (New York City, Westchester/Rockland, Long Island, Rest of New York State), age, sex, race and ethnicity. Main Outcomes: Primary outcome: cumulative incidence of SARS-CoV-2 infection, based on dry-blood spot (DBS) SARS-CoV-2 antibody reactivity; secondary outcome: percent of infections diagnosed. Results: Among 15,101 adults with suitable DBS specimens, 1,887 (12.5%) were reactive using a validated SARS-CoV-2 IgG microsphere immunoassay (sensitivity 87.9%, specificity 99.75%). Following post-stratification weighting on region, sex, age, and race and ethnicity and adjustment for assay characteristics, estimated cumulative incidence through March 29 was 14.0% (95% CI: 13.3-14.7%), corresponding to 2,139,300 (95% CI: 2,035,800-2,242,800) infection-experienced adults. Cumulative incidence was higher among Hispanic/Latino (29.2%, 95% CI: 27.2-31.2%), non-Hispanic black/African American (20.2% 95% CI, 18.1-22.3%), and non-Hispanic Asian (12.4%, 95% CI: 9.4-15.4%) adults than non-Hispanic white adults (8.1%, 95% CI: 7.4-8.7%, p<.0001). Cumulative incidence was highest in New York City (NYC) 22.7% (95% CI: 21.5%-24.0). Dividing diagnoses reported to NYS by estimated infection-experienced adults, an estimated 8.9% (95% CI: 8.4-9.3%) of infections were diagnosed, with those ≥55 years most likely to be diagnosed (11.3%, 95% CI: 10.4-12.2%). Conclusions and Relevance: Over 2 million adults were infected through late March 2020, with substantial variations by subpopulations. As this remains below herd immunity thresholds, monitoring, testing, and contact tracing remain essential public health strategies.

3 February 2020 in Journal of Public Health Management & Practice
Verified
Journal Article
Open access
MJMegan C. Johnson
Megan C. Johnson
RCRakkoo Chung
Rakkoo Chung
SLShu-Yin J. Ma Leung
Shu-Yin J. Ma Leung
ZEZoe Edelstein
Zoe Edelstein
YYYingchao Ma Yuan
Yingchao Ma Yuan
SFSusan M. Flavin
Susan M. Flavin
Context: Gay, bisexual, and men who have sex with men (MSM) are disproportionately affected by the HIV/AIDS epidemic more than any other group. In New York State (NYS) outside of New York City (NYC), MSM accounted for 57% of new HIV/AIDS diagnoses in 2017. HIV/AIDS home testing initiatives have been effective at getting priority populations tested for HIV. Objectives: The NYS Department of Health (NYSDOH) administered the HIV Home Test Giveaway (HHTG) program through social media and mobile applications popular among the priority populations to (1) promote HIV screening among gay and bisexual men, MSM, transgender (TG), and gender queer/gender nonconforming (GNC) individuals who have sex with men, and (2) identify individuals with undiagnosed HIV infection. Design/Setting: The NYSDOH recruited participants from NYS (excluding NYC) through social media campaigns between November 2016 and January 2018. Interested individuals were directed to an online eligibility survey. Eligible participants received a coupon via e-mail for a free HIV self-test (HIVST) kit through the manufacturer's Web site. Eligible participants received a $20 to $25 Amazon online gift card if they completed a voluntary online follow-up survey regarding their test results, experiences with the HHTG, and HIV/AIDS risk behaviors. Participants were also able to request assistance from the NYSDOH with further testing and various prevention and supportive services. Participants: In total, 6190 individuals participated and 3197 (52%) were eligible and received a coupon. Of the eligible, 2022 (63%) redeemed coupons for HIVST. Results: Among eligible participants, 976 (31%) reported having never been tested for HIV. On the follow-up survey, 922 (29%) participants reported having used the HIVST kit for themselves; 203 (22%) were first-time testers; and 7 (0.8%) tested HIV reactive. Of the follow-up survey participants, 761 (59%) requested assistance with various services. Conclusions: Media campaigns were effective in promoting HIV testing among priority populations and reaching individuals who have never been tested for HIV.

16 April 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RCRakkoo Chung
Rakkoo Chung
SLShu-Yin John Leung
Shu-Yin John Leung
SAStephen N. Abel
Stephen N. Abel
MHMichael N. Hatton
Michael N. Hatton
Yanfang RenYanfang Ren
Yanfang Ren
LOLaura O’sHea
Laura O’sHea
While primary care providers in New York State (NYS) are mandated to offer all patients a HIV test, still many NYS residents miss the HIV screening opportunity. To fill the gap, and as the CDC recommends, this study aimed to examine the feasibility of implementing HIV screening in dental setting, identify patient characteristics associated with acceptance of HIV rapid testing, and discuss best practices of HIV screening in dental setting. New York State Department of Health (NYSDOH) collaborated with the Northeast/Caribbean AIDS Education and Training Center (NECA AETC) and three dental schools in New York State to offer free HIV screening tests as a component of routine dental care between February 2016 and March 2018. Ten clinics in upstate New York and Long Island participated in the study. HIV screening was performed using the OraQuick™ In-Home HIV Test. 14,887 dental patients were offered HIV screening tests; 9,057 (60.8%) were screened; and one patient (0.011%) was confirmed HIV positive and linked to medical care. Of all dental patients, 33% had never been screened for HIV; and 56% had not had a primary care visit or had not been offered an HIV screening test by primary care providers in the previous 12 months. Multi-level generalized linear modeling analysis indicated that test acceptance was significantly associated with patient’s age, race/ethnicity, gender, country of origin, primary payer (or insurance), past primary care visits, past HIV testing experiences, and the poverty level of patient’s community. HIV screening is well accepted by dental patients and can be effectively integrated into routine dental care. HIV screening in the dental setting can be a good option for first-time testers, those who have not seen a primary care provider in the last 12 months, and those who have not been offered HIV screening at their last primary care visit.

22 February 2001 in New England Journal of Medicine
Verified
Journal Article
Closed access
HHH W Haverkos
H W Haverkos
RCR C Chung
R C Chung
To the Editor: The Centers for Disease Control and Prevention (CDC) tabulates and reports AIDS cases in the United States biannually. Using these official data, we analyzed trends in the distribution of AIDS cases according to sex, race or ethnic group, and various categories of exposure to human immunodeficiency virus (HIV); we analyzed trends for five-year intervals using end-of-the-year data from 1989, 1994, and 1999.13 Both the 1993 change in the case definition of AIDS4 and the increasing use of highly active antiretroviral therapy for HIV-infected persons5 complicate the interpretation of these surveillance data, but they probably have a . . .

1 February 2021 in Sexually Transmitted Diseases
Verified
Journal Article
Open access
MJManjiri Joshi
Manjiri Joshi
YYYingchao Ma Yuan
Yingchao Ma Yuan
WMWilson Miranda
Wilson Miranda
RCRakkoo Chung
Rakkoo Chung
DRDeepa T. Rajulu
Deepa T. Rajulu
RHRachel Hart-Malloy
Rachel Hart-Malloy
During the initial height of COVID-19 in New York State excluding New York City in March 2020, reports of sexually transmitted infections declined. Prediction models developed to estimate the incidence of early syphilis and gonorrhea during the COVID-19 pandemic were used to study impact on STI diagnoses/reporting and inform sexual health program planning.